Arete Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,387
Closed -$5.79M 551
2025
Q4
$5.79M Sell
5,387
-208
-4% -$199K 0.35% 63
2025
Q3
$4.28M Buy
5,595
+735
+15% +$547K 0.27% 83
2025
Q2
$3.79M Sell
4,860
-1,177
-19% -$915K 0.27% 80
2025
Q1
$4.99M Sell
6,037
-1,417
-19% -$1.18M 0.38% 56
2024
Q4
$5.75M Buy
7,454
+2,016
+37% +$1.67M 0.41% 50
2024
Q3
$4.8M Sell
5,438
-1,894
-26% -$1.7M 0.41% 56
2024
Q2
$6.65M Buy
+7,332
New +$5.87M 0.55% 33
2024
Q1
Sell
-5,445
Closed -$3.17M 572
2023
Q4
$3.17M Buy
5,445
+704
+15% +$411K 0.24% 85
2023
Q3
$2.55M Sell
4,741
-354
-7% -$182K 0.44% 53
2023
Q2
$2.39M Buy
5,095
+674
+15% +$283K 0.21% 104
2023
Q1
$1.52M Buy
4,421
+628
+17% +$212K 0.12% 150
2022
Q4
$1.39B Buy
3,793
+781
+26% +$277K 0.12% 149
2022
Q3
$974K Buy
3,012
+1,117
+59% +$354K 0.1% 182
2022
Q2
$614K Sell
1,895
-170
-8% -$51K 0.06% 208
2022
Q1
$591K Buy
2,065
+178
+9% +$45.8K 0.05% 255
2021
Q4
$520K Buy
1,887
+515
+38% +$131K 0.04% 281
2021
Q3
$317K Buy
+1,372
New +$339K 0.04% 319
2021
Q2
Sell
-1,430
Closed -$267K 412
2021
Q1
$267K Sell
1,430
-5
-0.3% -$978 0.03% 339
2020
Q4
$238K Buy
+1,435
New +$214K 0.03% 350

Other funds holding LLY

Arete Wealth Advisors's LLY Position: Q1 2026 in Review

Arete Wealth Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,387 shares — an estimated $5.79M sold.

Arete Wealth Advisors first reported a position in LLY in Q4 2020 and held it in 19 quarters. The position peaked at $1.39B in Q4 2022. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Arete Wealth Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 5,387 Eli Lilly shares in Q1 2026, an estimated $5.79M.
  • Arete Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and held it in 19 quarters.
  • Arete Wealth Advisors's Eli Lilly position peaked at $1.39B in Q4 2022.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.